Cargando…

Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells

Epithelial ovarian carcinoma is the most lethal gynecological cancer due to its silent onset and recurrence with resistance to chemotherapy. Overexpression of oncogene c-Myc is one of the most frequently encountered events present in ovarian carcinoma. Disrupting the function of c-Myc and its downst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jiandong, Ma, Xiaoli, Jones, Hannah M, Chan, Leo Li-Ying, Song, Fang, Zhang, Weiyuan, Bae-Jump, Victoria L, Zhou, Chunxiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160551/ https://www.ncbi.nlm.nih.gov/pubmed/25143136 http://dx.doi.org/10.1186/s12967-014-0226-x

Ejemplares similares

Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5
por: Wang, Huabo, et al.
Publicado: (2013)

MYC–MAX heterodimerization is essential for the induction of major zygotic genome activation and subsequent preimplantation development
por: Yamamoto, Takuto, et al.
Publicado: (2023)

Erratum: Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5
por: Wang, Huabo, et al.
Publicado: (2018)

A novel inhibitor L755507 efficiently blocks c-Myc–MAX heterodimerization and induces apoptosis in cancer cells
por: Singh, Ashutosh, et al.
Publicado: (2021)

Novel dual-targeting c-Myc inhibitor D347-2761 represses myeloma growth via blocking c-Myc/Max heterodimerization and disturbing its stability
por: Yao, Ruosi, et al.
Publicado: (2022)

The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer
por: Suri, Anuj, et al.
Publicado: (2016)

JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer*
por: Qiu, Haifeng, et al.
Publicado: (2015)

Max deletion destabilizes MYC protein and abrogates Eµ-Myc lymphomagenesis
por: Mathsyaraja, Haritha, et al.
Publicado: (2019)

Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer
por: Jackson, Amanda L., et al.
Publicado: (2017)

Mnt–Max to Myc–Max complex switching regulates cell cycle entry
por: Walker, William, et al.
Publicado: (2005)

SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer
por: Tran, Arthur-Quan, et al.
Publicado: (2021)

Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway
por: Yuan, Lingqin, et al.
Publicado: (2015)

Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer
por: Fan, Yali, et al.
Publicado: (2022)

MYC-Associated Factor MAX is a Regulator of the Circadian Clock
por: Blaževitš, Olga, et al.
Publicado: (2020)

A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation
por: Castell, Alina, et al.
Publicado: (2018)

MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner
por: Castell, Alina, et al.
Publicado: (2022)

Oesophageal adenocarcinoma is associated with a deregulation in the MYC/MAX/MAD network
por: Boult, J K R, et al.
Publicado: (2008)

In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential
por: Raffeiner, Philipp, et al.
Publicado: (2014)

Heterodimeric Plasmonic Nanogaps for Biosensing
por: Chatterjee, Sharmistha, et al.
Publicado: (2018)

A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression
por: Holmes, Austin G., et al.
Publicado: (2022)

Functional Myc-Max heterodimer is required for activation-induced apoptosis in T cell hybridomas
Publicado: (1994)

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
por: Wang, Huabo, et al.
Publicado: (2015)

Heterodimeric DNA motif synthesis and validations
por: Wong, Ka-Chun, et al.
Publicado: (2019)

Heterodimeric IL-15 in Cancer Immunotherapy
por: Bergamaschi, Cristina, et al.
Publicado: (2021)

Design and Characterization of pMyc/pMax Peptide-Coupled Gold Nanosystems for Targeting Myc in Prostate Cancer Cell Lines
por: Longoria-García, Samuel, et al.
Publicado: (2023)

Pharmacogenomic Identification of c-Myc/Max-Regulated Genes Associated with Cytotoxicity of Artesunate towards Human Colon, Ovarian and Lung Cancer Cell Lines
por: Sertel, Serkan, et al.
Publicado: (2010)

N-MYC DOWN-REGULATED-LIKE Proteins Regulate Meristem Initiation by Modulating Auxin Transport and MAX2 Expression
por: Mudgil, Yashwanti, et al.
Publicado: (2013)

The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer
por: Stine, Jessica E., et al.
Publicado: (2015)

Myc/Max dependent intronic long antisense noncoding RNA, EVA1A-AS, suppresses the expression of Myc/Max dependent anti-proliferating gene EVA1A in a U2 dependent manner
por: Niehus, Svenja E., et al.
Publicado: (2019)

Emerging Roles of TWIK-1 Heterodimerization in the Brain
por: Cho, Chang-Hoon, et al.
Publicado: (2017)

Early Archean origin of heterodimeric Photosystem I
por: Cardona, Tanai
Publicado: (2018)

Quantitative Supramolecular Heterodimerization for Efficient Energy Transfer
por: Wu, Guanglu, et al.
Publicado: (2020)

Analysis of Heterodimeric “Mutual Synergistic Folding”-Complexes
por: Mentes, Anikó, et al.
Publicado: (2019)

Asparagus officinalis combined with paclitaxel exhibited synergistic anti-tumor activity in paclitaxel-sensitive and -resistant ovarian cancer cells
por: Zhang, Xin, et al.
Publicado: (2022)

RUNX3 inactivates oncogenic MYC through disruption of MYC/MAX complex and subsequent recruitment of GSK3β-FBXW7 cascade
por: Oei, Vincent, et al.
Publicado: (2023)

Multiplex Detection of Homo- and Heterodimerization of G Protein-Coupled Receptors by Proximity Biotinylation
por: Steel, Elisabeth, et al.
Publicado: (2014)

Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines.
por: Hirvonen, H. E., et al.
Publicado: (1994)

Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain
por: Crouch, D. H., et al.
Publicado: (2005)

The Max b-HLH-LZ Can Transduce into Cells and Inhibit c-Myc Transcriptional Activities
por: Montagne, Martin, et al.
Publicado: (2012)

Sequence-specific DNA binding by MYC/MAX to low-affinity non-E-box motifs
por: Allevato, Michael, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6123rdu8js7a4b9p5lrcavtasd